Literature DB >> 24569891

Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.

Jian Chen1, Derick M Todd, Mélèze Hocini, Torben Bjerregaard Larsen, Maria Grazia Bongiorni, Carina Blomström-Lundqvist.   

Abstract

The purpose of this EP Wire survey was to assess clinical practice in periprocedural management of atrial fibrillation ablation. This survey is based on an electronic questionnaire sent to the European Heart Rhythm Association Research Network members. Responses were received from 78 centres in 20 countries. The results of the survey have shown that periprocedural management is generally in accordance with guidelines and consensus recommendations on ablation for atrial fibrillation ablation, although there are some areas of variation. Differences between high- and low-volume centres are observed with respect to patient selection, antiarrhythmic drug management, and heparin bridging.

Entities:  

Keywords:  Ablation; Anticoagulation; Atrial fibrillation; EHRA survey; EP wire; Periprocedural management

Mesh:

Year:  2014        PMID: 24569891     DOI: 10.1093/europace/euu043

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Authors:  Riccardo Cappato; Francis E Marchlinski; Stefan H Hohnloser; Gerald V Naccarelli; Jim Xiang; David J Wilber; Chang-Sheng Ma; Susanne Hess; Darryl S Wells; George Juang; Johan Vijgen; Burkhard J Hügl; Richard Balasubramaniam; Christian De Chillou; D Wyn Davies; L Eugene Fields; Andrea Natale
Journal:  Eur Heart J       Date:  2015-05-14       Impact factor: 29.983

2.  Management and Outcome of Periprocedural Cardiac Perforation and Tamponade with Radiofrequency Catheter Ablation of Cardiac Arrhythmias: A Single Medium-Volume Center Experience.

Authors:  Nebojša Mujović; Milan Marinković; Nebojša Marković; Aleksandar Kocijančić; Vladan Kovačević; Dragan Simić; Arsen Ristić; Goran Stanković; Biljana Miličić; Svetozar Putnik; Bosiljka Vujisić-Tešić; Tatjana S Potpara
Journal:  Adv Ther       Date:  2016-08-23       Impact factor: 3.845

Review 3.  Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.

Authors:  Nebojša Mujović; Milan Marinković; Radoslaw Lenarczyk; Roland Tilz; Tatjana S Potpara
Journal:  Adv Ther       Date:  2017-07-21       Impact factor: 3.845

4.  Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study.

Authors:  Hugh Calkins; Stephan Willems; Atul Verma; Richard Schilling; Stefan H Hohnloser; Ken Okumura; Matias Nordaby; Eva Kleine; Branislav Bis; Edward P Gerstenfeld
Journal:  Europace       Date:  2019-06-01       Impact factor: 5.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.